164 related articles for article (PubMed ID: 10857913)
41. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.
Yasui H; Adachi Y; Katoh A; Sakurai H
J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093
[TBL] [Abstract][Full Text] [Related]
42. The cellular intake kinetics and acute biological effects of various oxovanadium species: a comparative study.
Reuland DJ; Cao ZX; Rosenhein L; Poehlein S; McCoy L; Turner J; Durham T; Ganguli S
Horm Metab Res; 1998 Jan; 30(1):29-33. PubMed ID: 9503035
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
44. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
[TBL] [Abstract][Full Text] [Related]
45. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
46. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and characterization of unsymmetrical oxidovanadium complexes: DNA-binding, cleavage studies and antitumor activities.
Lu J; Guo H; Zeng X; Zhang Y; Zhao P; Jiang J; Zang L
J Inorg Biochem; 2012 Jul; 112():39-48. PubMed ID: 22546685
[TBL] [Abstract][Full Text] [Related]
48. Alkoxo Bound Monooxo- and Dioxovanadium(V) Complexes: Synthesis, Characterization, X-ray Crystal Structures, and Solution Reactivity Studies.
Asgedom G; Sreedhara A; Kivikoski J; Valkonen J; Kolehmainen E; Rao CP
Inorg Chem; 1996 Sep; 35(19):5674-5683. PubMed ID: 11666761
[TBL] [Abstract][Full Text] [Related]
49. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and In Vitro Antitumor Activity of Two Mixed-Ligand Oxovanadium(IV) Complexes of Schiff Base and Phenanthroline.
Zhang Y; Wang X; Fang W; Cai X; Chu F; Liao X; Lu J
Bioinorg Chem Appl; 2013; 2013():437134. PubMed ID: 23424390
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
[TBL] [Abstract][Full Text] [Related]
52. Exploration of DNA binding mode, chemical nuclease, cytotoxic and apoptotic potentials of diketone based oxovanadium(IV) complexes.
Inamdar PR; Sheela A
Int J Biol Macromol; 2015 May; 76():269-78. PubMed ID: 25720830
[TBL] [Abstract][Full Text] [Related]
53. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
[TBL] [Abstract][Full Text] [Related]
54. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
55. New Oxidovanadium Complexes Incorporating Thiosemicarbazones and 1, 10-Phenanthroline Derivatives as DNA Cleavage, Potential Anticancer Agents, and Hydroxyl Radical Scavenger.
Ying P; Zeng P; Lu J; Chen H; Liao X; Yang N
Chem Biol Drug Des; 2015 Oct; 86(4):926-37. PubMed ID: 25659415
[TBL] [Abstract][Full Text] [Related]
56. Dinuclear copper(II) complexes with {Cu2(mu-hydroxo)bis(mu-carboxylato)}+ cores and their reactions with sugar phosphate esters: A substrate binding model of fructose-1,6-bisphosphatase.
Kato M; Tanase T; Mikuriya M
Inorg Chem; 2006 Apr; 45(7):2925-41. PubMed ID: 16562948
[TBL] [Abstract][Full Text] [Related]
57. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
[TBL] [Abstract][Full Text] [Related]
58. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
59. Physicochemical properties of ternary oxovanadium(IV) complexes with oxydiacetate and 1,10-phenanthroline or 2,2'-bipyridine. Cytoprotective activity in hippocampal neuronal HT22 cells.
Wyrzykowski D; Inkielewicz-Stępniak I; Pranczk J; Żamojć K; Zięba P; Tesmar A; Jacewicz D; Ossowski T; Chmurzyński L
Biometals; 2015 Apr; 28(2):307-20. PubMed ID: 25656562
[TBL] [Abstract][Full Text] [Related]
60. Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity.
Sun Y; Zheng Y; Lei WH; Zhou QX; Hou YJ; Zhang BW; Wang XS
Dalton Trans; 2012 Jan; 41(2):651-7. PubMed ID: 22068883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
